ABSTRACT. Spatial expression of messenger ribonucleic acid (mRNA) for osteoblastic marker in drill hole defect healing of adult male rats was analyzed by in situ hybridization. The defect was filled with hematoma 3 days after surgery, expressing Type I collagen mRNA. Hematoma was replaced with fibrous tissue on day 7, and then with new trabecular bone on day 10, originated from the intra-medullary space, respectively. mRNA for Type I collagen, parathyroid hormone 1 receptor (PTH1R), and alkaline phosphatase (ALP) were expressed in the same cell population of fibrous tissue adjacent to newly-formed trabecular bone, and in osteoblasts lining the newlyformed trabecular bone. Hematopoietic marrow with osteoclasts subsequently invaded the region, also from the intra-medullary space, replacing all the new trabecular bone by day 21, except for a thin sub-periosteal layer. mRNA for Type I collagen, PTH1R and ALP was expressed on the periosteal surface of thin layer. Although cartilage formation was not histologically visible, mRNA for Type II collagen was weakly detected in the majority of osteoblasts lining the newly-formed trabecular bone. KEY WORDS: bone defect healing, bone formation, bone resorption, in situ hybridization, osteoblast.
Repair of bone injuries, such as fractures, involves a sequential cellular program that culminates in local osteogenesis, with or without prior chondrogenesis [3] . Healing of a fracture requires apposition and fixation of the broken bone fragments [8] . Major separation or major movement of the separated fragments may prevent healing, but minor movement of opposed bone fragments stimulates the development of unmineralized and then mineralized callus around the fracture site [3] . A drill hole model, which is the stably fixed model to investigate the bone healing without the movement, has been utilized to analyze the bone regeneration by radiology and histology [6, 10] . Recently, the immunohistochemical technology enables to reveal the distribution of proteins related to bone formation [13] . However, the sequential molecular events involved in bone defect healing remain incompletely characterized.
In this study, we used in situ hybridization to characterize the spatial expression of mRNA for osteoblastic markers in and around drill holes in the femoral diaphysis of rats, at intervals during healing. The holes penetrated only one cortex and did not fracture the femur or interfere with postoperative standing or walking. Because 8-10-month-old male rats are already skeletally-mature and are easy to perform the bone defect surgery, we also avoided the complicating effects of rapid bone growth and irreproducibility of surgery.
MATERIALS AND METHODS

Surgery and collection of tissue:
We purchased twentyfive 8-10-month-old male Sprague Dawley/Zivic Miller rats. After acclimatizing them for approximately 1 week, we anesthetized them with ketamine and xylazine, and with aseptic technique exposed the lateral right femoral diaphysis with removing periosteum, and made three holes along its long axis with an electrically-driven 1.8 mm diameter drill bit. Each hole penetrated the cortex to the medullary cavity, but did not penetrate the opposite cortex, and approximately 5 mm of intact cortex separated adjacent holes. We stopped blood loss from the medullary cavity by applying cotton tips. Postoperatively we administered ampicillin at 50 mg/ kg/day. All rats were ambulatory as soon as they recovered from anesthesia, and no wound infections occurred in the animals reported here. The animal care was in accordance with the policies of Massachusetts General Hospital.
On days 3, 7, 10, 14 and 21 after surgery, we anesthetized the 5 rats with ether and then perfused their arterial circulation with freshly-prepared 4% paraformaldehyde (PFA) in phosphate-buffered saline at pH 7.4 (PBS) until they were exsanguinated. We then removed the right femurs, fixed them overnight in 4% PFA/PBS at 4°C, and decalcified them in 20% EDTA, 10% formalin in PBS for 2 weeks. We bisected each decalcified femur along its long axis, bisecting the three drilled holes so all would appear in the same section, and cut sections parallel to the open femoral surface, to encompass both cortices, the intervening medullary cavity, the three holes, and the femoral cortex proximal and distal to the holes. Frozen sections approximately 8 µm thick were prepared by the standard procedures using precoated glass slides (Super Frost Plus, Fisher Scientific, Hampton, NH In situ hybridization: Sections were post-fixed with freshly prepared 4% PFA/PBS for 15 min. After washing with PBS, the sections were digested with 1 µg/ml proteinase K (37°C, 15 min) in PBS, and again treated with 4% PFA/PBS (10 min) to inactivate proteinase K. Then sections were sequentially washed with PBS, treated with 0.2 N HCl (10 min), again washed with PBS, acetylated with 0.25% acetic anhydride in the presence of triethanolamine (0.1 M, 10 min), dehydrated with increasing concentrations of ethanol, and air-dried. Hybridizations with 35 S-labeled complementary RNA's (5 × 10 7 cpm/ml in a solution containing 50% formamide, 10% dextran sulfate, 1 × Denhardt's solution, 600 mM NaCl, 10 mM DTT, 0.25% SDS, and 150 µg/ml transfer RNA) were performed in a humidified chamber at 50°C for 18 hr. After hybridization, sections were sequentially washed briefly with 5 × SSC at 50°C, 50% formamide-2 × SSC at 50°C, and TNE (10 mM Tris-HCl pH 7.6, 500 mM NaCl, 1 mM EDTA), and then treated with 10 µg/ml ribonuclease A in TNE at 37°C for 30 min. After washing with TNE, sections were incubated once with 2 × SSC (50°C, 20 min), twice with 0.2 × SSC (50°C, 20 min × 2), dehydrated with increasing concentrations of ethanol, and air-dried. To estimate the exposure period for the emulsion autoradiography, the slides were placed on the X-ray film (HyperFilm β-max, Amersham, Arlington Heights, IL), and autoradiographs developed after overnight exposure. The slides were subsequently dipped into photo-emulsion (NTB-2, Eastman Kodak, New Haven, CT) and exposed at 4°C for the interval estimated from the intensity of expression on the X-ray film. After development of the photo-emulsion, the sections were counterstained with hematoxylin and eosin.
RESULTS
Histology of defect healing:
The bone defect area was filled with hematoma within 3 days after surgery (Fig. 1a) . By 7 days after surgery the hematoma was replaced by fibrous tissue (Fig. 1b) , on the marrow side of which active cuboidal osteoblasts congregated (Fig. 2a) . By 7 and/or 10 days after surgery, newly-formed trabecular bone replaced the fibrous tissue, starting from the marrow side of the defect and progressing toward the periosteal side (Fig. 1b,  c) . At the junction of the diminishing fibrous tissue and the newly-formed bone, cuboidal osteoblasts on trabecular bone surfaces resided adjacent to a population of spindle-shaped inter-trabecular stromal cells (Fig. 2b) . By 14 days after surgry, hematopoietic cells were observed in the inter-trabecular space of the newly formed bone, especially on the marrow side of the defect, and hematopoietic marrow had replaced part of the newly-formed bone in this area (Fig.   1d ). Spindle shaped stromal cells and active osteoblasts were not prominent in this area, however multinuclear osteoclasts appeared (Fig. 2c) . By 21 days after surgery, hematopoietic marrow had replaced all the newly-formed trabecular bone, except for a thin layer on the periosteal side of the defect (Fig. 1e) . At no time during this interval (3 through 21 days after the surgery) did we observe cells or tissue with the classical histological charactaristics of chondrocytes or cartilage in the defect area. The difference of healing process by the location of defect in each femur was not observed.
mRNA expression during defect healing: By 3 days after surgery, type I collagen mRNA was detected in cells on the marrow side of the hematoma (Fig. 3a) , and by 7 and 10 days after surgery type I collagen mRNA was detected in cells on the surface of the newly-formed trabecular bone, and in adjacent fibrous tissue cells (Fig. 3b, c) . Also, by days 14 and 21 type I collagen mRNA was detected in cells on the surface of the newly-formed bone (Fig. 3d, e) .
PTH1R mRNA was not detected in the hematoma (Fig.  3f) , however by days 7 and 10 it was strongly expressed in fibrous tissue cells adjacent to newly-formed bone, as well as in osteoblasts on the surface of the newly-formed trabecular bone, which is already known (Fig. 3g, h ). On days 14 and 21, weak expression of PTH1R mRNA was observed on the periosteal surface of the thin shell of bone remaining on the periosteal side of the defect (Fig. 3i, j) .
The localization of alkaline phosphatase mRNA resembled that of PTH1R mRNA, but alkaline phosphatase mRNA had a broader distribution and was visualized at a higher intensity. Alkaline phosphatase mRNA was not detected in the hematoma on day 3 (Fig. 3k) . However on days 7 through 14, it was seen in fibrous tissue cells adjacent to the newly-formed bone, and in osteoblasts on its surface (Fig. 3 l, m, n) . As the new trabecular bone was replaced by invading osteoclasts and hematopoietic marrow, alkaline phosphatase mRNA became less evident on the medullary surface of the remaining thin layer of new bone (Day 21, Fig. 3o ).
Type II collagen mRNA was not detected in the hematoma (Fig. 3p) , however it was weakly detected on surfaces of newly-formed trabecular bone throughout the study (Fig. 3q-t) . The cells expressing Type II collagen mRNA were cuboidal osteoblasts on the surface of newly-formed trabecular bone (Fig. 4) .
DISCUSSION
We have investigated the spatial relationship of mRNA for osteoblastic markers during the course of bone defect healing process. Bone formation dominates the healing process until day 10, and bone resorption is dominant after day 14 as previous similar experiments [6, 13] . Furthermore, the initial bone formation phase histologically resembles the metal chamber implantation model in sheep [14] , although the initial bone formation is slower in the sheep model.
Starting from the marrow side of the defect, the initial hematoma was replaced by invading fibrous tissue whose cells expressed mRNA for PTH1R, alkaline phosphatase, and type I collagen. Expression of these mRNA is characteristic of bone-lining osteoblasts [5] , so the fibrous tissue that replaced the hematoma presumably contains osteoblasts or their precursors. Consistent with this hypothesis, the fibrous tissue was in turn replaced by newly-formed trabecular bone, in a gradient that also progressed from the marrow side to the periosteal side of the defect. Until day 10, most of the cells lining this new bone were cuboidal, which, together with their mRNA expression pattern, suggests they were actively forming new bone [4] . These observations are consistent with a dynamic temporal evolution of cell phenotypes within the defect, starting with fibroblasts and progressing to osteoblastic precursors, and then osteoblasts. The type II collagen mRNA, we repeatedly detected as a faint signal on the surface of newly-formed trabecular bone, may be expressed in active osteoblasts, because of their morphology. The fact that we never observed cells with the morphologic characteristics of chondrocytes nor cartilage as other study already reported in this bone defect model [6, 10] also supports this hypothesis. Expression of mRNA for type II collagen may in the past have been considered specific to chondrocytes [5, 9] , however recent investigations indicate that type II collagen mRNA is transiently expressed in osteoblasts in embryonic calvarial bone [7] and in osteoblasts of repairing fracture callus [1] . Although we have not examined the production of chondrogenic matrix in the defect area, the similarity of ossification may exist in the osteogenesis during the bone formation phase in the current model and in the intramembranous bone formation such as in calvaria [7] .
Osteoclasts resorbed most of the new trabecular bone after day 14, and the discontinuity in the diaphyseal cortex was larger at day 21 than at day 10. Healing was still active 3 weeks after the surgery. It is unclear why the initial wave of primary osteogenesis, which progressed from the marrow side of the defect to its periosteal side, was followed by a temporally separate wave of bone resorption, which also progressed from the marrow side of the defect to its periosteal side. This regular sequence of primary bone formation followed by bone resorption, along a coordinated spatial gradient, resembles the sequence observed after the bone marrow is experimentally flushed out of a rat long bone's medullary cavity (bone marrow ablation) [12] . Initially the former marrow space fills with new trabecular bone, which hematopoietic marrow subsequently replaces. Parallel molecular mechanisms may underlie healing in the present model and in the bone marrow ablation model, a hypothesis that can be evaluated by comparing mRNA expression and protein secretion in these two models.
Current bone defect model may be a non-healing bone injury model up until 21 days after surgery, so that the healing process between the current model and a lengthened human tibia [11] may be similar. Although healing process in longer duration should be investigated to confirm the healing process, the efficacy of bone anabolic agent can be evaluated in this model. mRNA for the PTH1R was expressed along the surfaces of the trabecular bone that initially filled these diaphyseal bone defects. PTH has strong bone anabolic effect when it is exogenously given by intermittent manner [2] . Endogenously secreted and/or exogenously administered PTH therefore might alter their healing diaphyseal defects 7, 10, and 14 days after defect surgery (a, b, and c, respectively). Cuboidal osteoblasts (arrow) were observed in newly formed fibrous tissue (day 7), on the surface of new trabecular bone (day 10), while spindle-shaped stromal cells (arrow head) filled the inter-trabecular space (both days). By day 14 stromal cells were less frequent in the inter-trabecular space, but hematopoietic cells were prominent there, and multi-nucleated osteoclasts (arrow) were frequently seen on trabecular bone surfaces, suggesting bone resorption.
in the current defect model. We are currently testing this possibility experimentally. Fig. 3 . Autoradiographic visualization of mRNA in typical regions of diaphyseal defects collected 3, 7, 10, 14, and 21 days after defect surgery (dark field illumination, magnified × 10). a, b, c, d, and e: type I collagen mRNA on days 3, 7, 10, 14, and 21, respectively. Type I collagen mRNA was observed in fibrous tissue at Day 3, and on the surface of newly formed trabecular bone. f, g, h, i, and j: PTH1 receptor mRNA on days 3, 7, 10, 14, and 21, respectively. PTH1 receptor mRNA was observed in fibrous tissue near its interface with newly-formed trabecular bone at days 7 and 10, and thereafter on the surface of newly-formed trabecular bone. k, l, m, n, and o: alkaline phosphatase mRNA on days 3, 7, 10, 14, and 21, respectively. Alkaline phosphatase mRNA was detected in the same areas as PTH1 receptor mRNA, but more intensely and/or in more cells. p, q, r, s, and t: type II collagen mRNA on days 3, 7, 10, 14, and 21, respectively. u, v, w, x, and y: alkaline phosphatase mRNA on days 3, 7, 10, 14, and 21, respectively (bright-field illumination). Alkaline phophatase mRNA was slightly expressed on the surface of newly formed trabecular bone. 
